Platelet function and Isoprostane biology. Should Isoprostanes be the newest member of the Orphan-ligand family?

Journal of Biomedical Science

Volumn 17, Issue 1, 2010, Pages

  Ting, Harold J ^a   Khasawneh, Fadi T ^a  

^a WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; 8 ISOPROSTAGLANDIN F3 ALPHA; ARACHIDONIC ACID; ISOPROSTANE DERIVATIVE; LIGAND; ORPHAN LIGAND; THROMBOXANE A2; UNCLASSIFIED DRUG;

HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION; CHEMICAL STRUCTURE; CHEMISTRY; HEMOSTASIS; METABOLISM; PHYSIOLOGY; THROMBOCYTE;

ARACHIDONIC ACID; BLOOD PLATELETS; HEMOSTASIS; HUMANS; ISOPROSTANES; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PLATELET ACTIVATION; SIGNAL TRANSDUCTION;

EID: 77950522051     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-17-24     Document Type: Review

References (115)

1. Platelet activation. MB Zucker VT Nachmias, Arteriosclerosis 1985 5 2 18
2. Coagulation and platelet activation pathways. A review of the key components and the way in which these can be manipulated. HR Buller T Ten Cate, Eur Heart J 1995 16 Suppl L 8 10
3. Laboratory investigation of platelet function: a review of methodology. DA Yardumian IJ Mackie SJ Machin, J Clin Pathol 1986 39 701 712 (Pubitemid 16069476)
4. Platelet function defects: a clinical review. RL Bick, Semin Thromb Hemost 1992 18 167 185
5. Thrombin-initiated platelet activation in vivo is vWF independent during thrombus formation in a laser injury model. C Dubois L Panicot-Dubois JF Gainor BC Furie B Furie, J Clin Invest 2007 117 953 960 (Pubitemid 46556751)
6. Conversion from chronic to acute coronary heart disease syndromes. Role of platelets and platelet products. JT Willerson, Tex Heart Inst J 1995 22 13 19
7. Clinical and biochemical characteristics of a primary platelet disorder. MA Sahud, Acta Univ Carol Med Monogr 1972 53 317 324
8. The role of blood platelets in nucleoside metabolism: regulation of megakaryocyte development and platelet production. T Shaw, Mutat Res 1988 200 67 97
9. Aspirin as an antiplatelet drug. C Patrono, N Engl J Med 1994 330 1287 1294 (Pubitemid 24129964)
10. Regulation of megakaryocytopoiesis. H Avraham, Stem Cells 1993 11 499 510 (Pubitemid 23352918)
11. Dynamics of platelet thrombus formation. SP Jackson WS Nesbitt E Westein, J Thromb Haemost 2009 7 Suppl 1 17 20
12. Aggregation of blood platelets by adenosine diphosphate and its reversal. GV Born, Nature 1962 194 927 929
13. Interrelations of platelet aggregation and secretion. IF Charo RD Feinman TC Detwiler, J Clin Invest 1977 60 866 873
14. Characterization of U46619 binding in unactivated, intact human platelets and determination of binding site affinities of four TXA2/PGH2 receptor antagonists (13-APA, BM 13.177, ONO 3708 and SQ 29,548). EJ Kattelman DL Venton GC Le Breton, Thromb Res 1986 41 471 481
15. Thromboxane A2/prostaglandin H2 directly stimulates platelet shape change independent of secreted ADP. LV Parise DL Venton GC Le Breton, J Pharmacol Exp Ther 1982 222 276 281
16. Ligand density dramatically affects integrin alpha IIb beta 3-mediated platelet signaling and spreading. M Jirouskova JK Jaiswal BS Coller, Blood 2007 109 5260 5269 (Pubitemid 46890546)
17. Thromboxane A2 biosynthesis in human disease. GA FitzGerald C Healy J Daugherty, Fed Proc 1987 46 154 158
18. Effects of the lonophore A23187 on the blood platelets II. Influence on ultrastructure. JM Gerrard JG White GH Rao, Am J Pathol 1974 77 151 166
19. Platelet alpha-granule proteins: studies on release and subcellular localization. KL Kaplan MJ Broekman A Chernoff GR Lesznik M Drillings, Blood 1979 53 604 618 (Pubitemid 9154938)
20. Platelet alpha-granules. P Harrison EM Cramer, Blood Rev 1993 7 52 62
21. Comparative study of platelet dense granule constituents. KM Meyers H Holmsen CL Seachord, Am J Physiol 1982 243 454 461
22. Platelet dense granules: structure, function and implications for haemostasis. A McNicol SJ Israels, Thromb Res 1999 95 1 18
23. Changes in the cytoskeletal structure of human platelets following thrombin activation. LK Jennings JE Fox HH Edwards DR Phillips, J Biol Chem 1981 256 6927 6932
24. Cytosolic calcium in platelet activation. TJ Rink, Experientia 1988 44 97 100
25. Signaling through platelet integrin alpha IIb beta 3: inside-out, outside-in, and sideways. SJ Shattil, Thromb Haemost 1999 82 318 325
26. Is thrombin the problem or (dis)solution? JF Arthur SP Jackson, Blood 2009 113 6046 6047
27. Epinephrine induced platelet aggregation in rat platelet-rich plasma. HS Yun-Choi KM Park MK Pyo, Thromb Res 2000 100 511 518
28. Inhibition of adenosine diphosphate-induced secondary aggregation and other platelet functions by acetylsalicylic acid ingestion. MB Zucker J Peterson, Proc Soc Exp Biol Med 1968 127 547 551
29. Signaling mechanisms mediated by G-protein coupled receptors in human platelets. SA Saeed H Rasheed FA Fecto MI Achakzai R Ali JD Connor AU Gilani, Acta Pharmacol Sin 2004 25 887 892
30. Prostaglandin endoperoxides and thromboxane A2 can induce platelet aggregation in the absence of secretion. IF Charo RD Feinman TC Detwiler JB Smith CM Ingerman MJ Silver, Nature 1977 269 66 69
31. Rapid, agonist-dependent phosphorylation in vivo of human thromboxane receptor isoforms. Minimal involvement of protein kinase C. A Habib R Vezza C Creminon J Maclouf GA FitzGerald, J Biol Chem 1997 272 7191 7200
32. Phosphorylation of the thromboxane receptor alpha, the predominant isoform expressed in human platelets. A Habib GA FitzGerald J Maclouf, J Biol Chem 1999 274 2645 2651
33. Agonist receptors and G proteins as mediators of platelet activation. LF Brass JA Hoxie T Kieber-Emmons DR Manning M Poncz M Woolkalis, Adv Exp Med Biol 1993 344 17 36
34. G proteins: transducers of receptor-generated signals. AG Gilman, Annu Rev Biochem 1987 56 615 649
35. The G protein coupled to the thromboxane A2 receptor in human platelets is a member of the novel Gq family. A Shenker P Goldsmith CG Unson AM Spiegel, J Biol Chem 1991 266 9309 9313
36. G proteins. JR Hepler AG Gilman, Trends Biochem Sci 1992 17 383 387
37. Galpha12 and galpha13 are phosphorylated during platelet activation. S Offermanns YH Hu MI Simon, J Biol Chem 1996 271 26044 26048
38. Identification of Gq as one of the G-proteins which copurify with human platelet thromboxane A2/prostaglandin H2 receptors. I Knezevic C Borg GC Le Breton, J Biol Chem 1993 268 26011 26017
39. Subcellular localization of alpha-subunits of trimeric G-proteins in human platelets. AN Giesberts M van Ginneken G Gorter EG Lapetina JW Akkerman G van Willigen, Biochem Biophys Res Commun 1997 234 439 444
40. Gq/11 communicates with thromboxane A2 receptors in human astrocytoma cells, rabbit astrocytes and human platelets. N Nakahata A Miyamoto S Ohkubo H Ishimoto K Sakai H Nakanishi H Ohshika Y Ohizumi, Res Commun Mol Pathol Pharmacol 1995 87 243 251
41. Identification of Galpha13 as one of the G-proteins that couple to human platelet thromboxane A2 receptors. Y Djellas JM Manganello K Antonakis GC Le Breton, J Biol Chem 1999 274 14325 14330
42. The human thromboxane A2 receptor alpha isoform (TP alpha) functionally couples to the G proteins Gq and G11 in vivo and is activated by the isoprostane 8-epi prostaglandin F2 alpha. BT Kinsella DJ O'Mahony GA Fitzgerald, J Pharmacol Exp Ther 1997 281 957 964
43. Production of diglyceride from phosphatidylinositol in activated human platelets. S Rittenhouse-Simmons, J Clin Invest 1979 63 580 587
44. Significance of PIP2 hydrolysis and regulation of phospholipase C isozymes. SB Lee SG Rhee, Curr Opin Cell Biol 1995 7 183 189
45. Release of Ca2+ from a nonmitochondrial intracellular store in pancreatic acinar cells by inositol-1,4,5-trisphosphate. H Streb RF Irvine MJ Berridge I Schulz, Nature 1983 306 67 69
46. myo-Inositol 1,4,5-trisphosphate. A second messenger for the hormonal mobilization of intracellular Ca2+ in liver. SK Joseph AP Thomas RJ Williams RF Irvine JR Williamson, J Biol Chem 1984 259 3077 3081
47. A role of calcium-activated phospholipid-dependent protein kinase in human platelet activation. Comparison of thrombin and collagen actions. K Sano Y Takai J Yamanishi Y Nishizuka, J Biol Chem 1983 258 2010 2013
48. Platelet signal transduction pathways: could we organize them into a 'hierarchy'? S Levy-Toledano, Haemostasis 1999 29 4 15
49. Platelets and anti-platelet therapy. A McNicol SJ Israels, J Pharmacol Sci 2003 93 381 396
50. The involvement of blood coagulation factor XIII in fibrinolysis and thrombosis. L Muszbek Z Bagoly Z Bereczky E Katona, Cardiovasc Hematol Agents Med Chem 2008 6 190 205
51. Purification of glycoproteins IIb and III from human platelet plasma membranes and characterization of a calcium-dependent glycoprotein IIb-III complex. LK Jennings DR Phillips, J Biol Chem 1982 257 10458 10466
52. G proteins of the G12 family are activated via thromboxane A2 and thrombin receptors in human platelets. S Offermanns KL Laugwitz K Spicher G Schultz, Proc Natl Acad Sci USA 1994 91 504 508
53. Differential requirements for calcium and Src family kinases in platelet GPIIb/IIIa activation and thromboxane generation downstream of different G-protein pathways. RT Dorsam S Kim S Murugappan S Rachoor H Shankar J Jin SP Kunapuli, Blood 2005 105 2749 2756
54. Rapid stimulation of tyrosine phosphorylation signals downstream of G-protein-coupled receptors for thromboxane A2 in human platelets. P Minuz L Fumagalli S Gaino RM Tommasoli M Degan C Cavallini A Lecchi M Cattaneo C Lechi Santonastaso G Berton, Biochem J 2006 400 127 134
55. Cyclooxygenases, thromboxane, and atherosclerosis: plaque destabilization by cyclooxygenase-2 inhibition combined with thromboxane receptor antagonism. KM Egan M Wang S Fries MB Lucitt AM Zukas E Pure JA Lawson GA FitzGerald, Circulation 2005 111 334 342
56. Galpha12 and Galpha13 stimulate Rho-dependent tyrosine phosphorylation of focal adhesion kinase, paxillin, and p130 Crk-associated substrate. LK Needham E Rozengurt, J Biol Chem 1998 273 14626 14632
57. Integrin signaling: the platelet paradigm. SJ Shattil H Kashiwagi N Pampori, Blood 1998 91 2645 2657
58. Crosstalk coregulation mechanisms of G protein-coupled receptors and receptor tyrosine kinases. K Natarajan BC Berk, Methods Mol Biol 2006 332 51 77
59. Fibrinogen binding is independent of an increase in intracellular calcium concentration in thrombin degranulated platelets. FM Pulcinelli JL Daniel S Riondino PP Gazzaniga L Salganicoff, Thromb Haemost 1995 73 304 308
60. Activation of phospholipases A and C in human platelets exposed to epinephrine: role of glycoproteins IIb/IIIa and dual role of epinephrine. HS Banga ER Simons LF Brass SE Rittenhouse, Proc Natl Acad Sci USA 1986 83 9197 9201
61. Costimulation of Gi- and G12/G13-mediated signaling pathways induces integrin alpha IIbbeta 3 activation in platelets. B Nieswandt V Schulte A Zywietz MP Gratacap S Offermanns, J Biol Chem 2002 277 39493 39498
62. Coordinated signaling through both G12/13 and G(i) pathways is sufficient to activate GPIIb/IIIa in human platelets. RT Dorsam S Kim J Jin SP Kunapuli, J Biol Chem 2002 277 47588 47595
63. Activation of platelet function through G protein-coupled receptors. S Offermanns, Circ Res 2006 99 1293 1304
64. Ras activation in platelets after stimulation of the thrombin receptor, thromboxane A2 receptor or protein kinase C. DD Shock K He JD Wencel-Drake LV Parise, Biochem J 1997 321 Pt 2 525 530
65. Activation of G12/G13 results in shape change and Rho/Rho-kinase-mediated myosin light chain phosphorylation in mouse platelets. B Klages U Brandt MI Simon G Schultz S Offermanns, J Cell Biol 1999 144 745 754
66. Differential regulation of Rho and Rac through heterotrimeric G-proteins and cyclic nucleotides. MP Gratacap B Payrastre B Nieswandt S Offermanns, J Biol Chem 2001 276 47906 47913
67. Platelet shape change is mediated by both calcium-dependent and -independent signaling pathways. Role of p160 Rho-associated coiled-coil-containing protein kinase in platelet shape change. BZ Paul JL Daniel SP Kunapuli, J Biol Chem 1999 274 28293 28300
68. Thromboxane A2: physiology/pathophysiology, cellular signal transduction and pharmacology. N Nakahata, Pharmacol Ther 2008 118 18 35
69. Synthesis and structure of the platelet aggregation factor thromboxane A2. SS Bhagwat PR Hamann WC Still S Bunting FA Fitzpatrick, Nature 1985 315 511 513 (Pubitemid 15232871)
70. Characterization of isoprostane signaling: evidence for a unique coordination profile of 8-iso-PGF(2alpha) with the thromboxane A(2) receptor, and activation of a separate cAMP-dependent inhibitory pathway in human platelets. FT Khasawneh JS Huang F Mir S Srinivasan C Tiruppathi GC Le Breton, Biochem Pharmacol 2008 75 2301 2315
71. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. JD Morrow KE Hill RF Burk TM Nammour KF Badr LJ Roberts, Proc Natl Acad Sci USA 1990 87 9383 9387
72. The isoprostanes. Current knowledge and directions for future research. JD Morrow LJ Roberts, Biochem Pharmacol 1996 51 1 9 (Pubitemid 126333940)
73. Isoprostanes: an overview and putative roles in pulmonary pathophysiology. LJ Janssen, Am J Physiol Lung Cell Mol Physiol 2001 280 1067 1082
74. Local amplification of platelet function by 8-Epi prostaglandin F2alpha is not mediated by thromboxane receptor isoforms. D Pratico EM Smyth F Violi GA FitzGerald, J Biol Chem 1996 271 14916 14924 (Pubitemid 26197573)
75. Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice. D Pratico RK Tangirala DJ Rader J Rokach GA FitzGerald, Nat Med 1998 4 1189 1192 (Pubitemid 28468835)
76. F(2)-isoprostanes: sensitive and specific non-invasive indices of lipid peroxidation in vivo. D Pratico, Atherosclerosis 1999 147 1 10 (Pubitemid 29486766)
77. Increased F2-isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo. D Pratico MYL V JQ Trojanowski J Rokach GA Fitzgerald, FASEB J 1998 12 1777 1783 (Pubitemid 28553673)
78. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. JD Morrow B Frei AW Longmire JM Gaziano SM Lynch Y Shyr WE Strauss JA Oates LJ Roberts, N Engl J Med 1995 332 1198 1203
79. Cytotoxicity of the E(2)-isoprostane 15-E(2t)-IsoP on oligodendrocyte progenitors. S Brault AK Martinez-Bermudez J Roberts QL Cui G Fragoso S Hemdan HN Liu F Gobeil Jr C Quiniou E Kermorvant-Duchemin C Lachance G Almazan DR Varma S Chemtob, Free Radic Biol Med 2004 37 358 366
80. Effects of a novel prostaglandin, 8-epi-PGF2 alpha, in rabbit lung in situ. M Banerjee KH Kang JD Morrow LJ Roberts JH Newman, Am J Physiol 1992 263 660 663
81. The putative role of isoprostanes in human cardiovascular physiology and disease: following the fingerprints. JL Cracowski, Heart 2003 89 821 822
82. The thromboxane receptor antagonist S18886 but not aspirin inhibits atherogenesis in apo E-deficient mice: evidence that eicosanoids other than thromboxane contribute to atherosclerosis. AJ Cayatte Y Du J Oliver-Krasinski G Lavielle TJ Verbeuren RA Cohen, Arterioscler Thromb Vasc Biol 2000 20 1724 1728
83. Involvement of thromboxane receptor in the proatherogenic effect of isoprostane F2alpha-III: evidence from apolipoprotein E- and LDL receptor-deficient mice. M Tang T Cyrus Y Yao L Vocun D Pratico, Circulation 2005 112 2867 2874
84. 8-epi PGF2 alpha generation during coronary reperfusion. A potential quantitative marker of oxidant stress in vivo. N Delanty MP Reilly D Pratico JA Lawson JF McCarthy AE Wood ST Ohnishi DJ Fitzgerald GA FitzGerald, Circulation 1997 95 2492 2499
85. Evidence that the F2-isoprostane, 8-epi-prostaglandin F2 alpha, is formed in vivo. JD Morrow TA Minton KF Badr LJ Roberts, Biochim Biophys Acta 1994 1210 244 248
86. Receptor-mediated mitogenic effect of thromboxane A2 in vascular smooth muscle cells. K Hanasaki T Nakano H Arita, Biochem Pharmacol 1990 40 2535 2542
87. Role of nonenzymatically generated prostanoid, 8-iso-PGF2 alpha, in pulmonary oxygen toxicity. CA Vacchiano GE Tempel, J Appl Physiol 1994 77 2912 2917
88. Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids. JD Morrow JA Awad HJ Boss IA Blair LJ Roberts, Proc Natl Acad Sci USA 1992 89 10721 10725
89. The F2-isoprostane, 8-epi-prostaglandin F2 alpha, a potent agonist of the vascular thromboxane/endoperoxide receptor, is a platelet thromboxane/ endoperoxide receptor antagonist. JD Morrow TA Minton LJ Roberts, Prostaglandins 1992 44 155 163
90. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets. K Yin PV Halushka YT Yan PY Wong, J Pharmacol Exp Ther 1994 270 1192 1196
91. Evidence for the distinct nature of F2-isoprostane receptors from those of thromboxane A2. M Fukunaga T Yura R Grygorczyk KF Badr, Am J Physiol 1997 272 477 483 (Pubitemid 127750702)
92. Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2 alpha, in the rat. Evidence for interaction with thromboxane A2 receptors. K Takahashi TM Nammour M Fukunaga J Ebert JD Morrow LJ Roberts RL Hoover KF Badr, J Clin Invest 1992 90 136 141
93. Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. OP Barry D Pratico JA Lawson GA FitzGerald, J Clin Invest 1997 99 2118 2127 (Pubitemid 27203768)
94. Cardiovascular responses to the isoprostanes iPF(2alpha)-III and iPE(2)-III are mediated via the thromboxane A(2) receptor in vivo. LP Audoly B Rocca JE Fabre BH Koller D Thomas AL Loeb TM Coffman GA FitzGerald, Circulation 2000 101 2833 2840
95. Augmented vasoconstriction and thromboxane formation by 15-F(2t)-isoprostane (8-iso-prostaglandin F(2alpha)) in immature pig periventricular brain microvessels. X Hou F Gobeil Jr K Peri G Speranza AM Marrache P Lachapelle J Roberts DR Varma S Chemtob EF Ellis, Stroke 2000 31 516 524
96. Evidence for the existence of F2-isoprostane receptors on rat vascular smooth muscle cells. M Fukunaga N Makita LJ Roberts JD Morrow K Takahashi KF Badr, Am J Physiol 1993 264 1619 1624
97. Actions of the E2-isoprostane, 8-ISO-PGE2, on the platelet thromboxane/endoperoxide receptor in humans and rats: additional evidence for the existence of a unique isoprostane receptor. AW Longmire LJ Roberts JD Morrow, Prostaglandins 1994 48 247 256
98. Lipid peroxidation and platelet activation in murine atherosclerosis. T Cyrus LX Tang J Rokach GA FitzGerald D Pratico, Circulation 2001 104 1940 1945 (Pubitemid 32983238)
99. Improved endothelial function by the thromboxane A2 receptor antagonist S 18886 in patients with coronary artery disease treated with aspirin. L Belhassen G Pelle JL Dubois-Rande S Adnot, J Am Coll Cardiol 2003 41 1198 1204 (Pubitemid 36384909)
100. Dimerization of the human receptors for prostacyclin and thromboxane facilitates thromboxane receptor-mediated cAMP generation. SJ Wilson AM Roche E Kostetskaia EM Smyth, J Biol Chem 2004 279 53036 53047 (Pubitemid 40051803)
101. Prostaglandin F2alpha (PGF2alpha) and the isoprostane, 8, 12-iso-isoprostane F2alpha-III, induce cardiomyocyte hypertrophy. Differential activation of downstream signaling pathways. P Kunapuli JA Lawson JA Rokach JL Meinkoth GA FitzGerald, J Biol Chem 1998 273 22442 22452 (Pubitemid 28399809)
102. Heterodimerization of G-protein-coupled receptors: pharmacology, signaling and trafficking. LA Devi, Trends Pharmacol Sci 2001 22 532 537 (Pubitemid 32913563)
103. Physiological significance of thromboxane A(2) receptor dimerization. M Sasaki K Miyosawa S Ohkubo N Nakahata, J Pharmacol Sci 2006 100 263 270
104. Oligomerization of the alpha and beta isoforms of the thromboxane A2 receptor: relevance to receptor signaling and endocytosis. G Laroche MC Lepine C Theriault P Giguere V Giguere MA Gallant A de Brum-Fernandes JL Parent, Cell Signal 2005 17 1373 1383 (Pubitemid 41206647)
105. Heterodimerization of beta1- and beta2-adrenergic receptor subtypes optimizes beta-adrenergic modulation of cardiac contractility. WZ Zhu K Chakir S Zhang D Yang C Lavoie M Bouvier TE Hebert EG Lakatta H Cheng RP Xiao, Circ Res 2005 97 244 251
106. Crosstalk between Galpha(i)- and Galpha(q)-coupled receptors is mediated by Gbetagamma exchange. U Quitterer MJ Lohse, Proc Natl Acad Sci USA 1999 96 10626 10631
107. Aggregation of human and canine platelets: modulation by purine nucleotides. G Soslau L Arabe J Parker A Pelleg, Thromb Res 1993 72 127 137
108. Concomitant activation of Gi and Gq protein-coupled receptors does not require an increase in cytosolic calcium for platelet aggregation. FM Pulcinelli M Pesciotti P Pignatelli S Riondino PP Gazzaniga, FEBS Lett 1998 435 115 118
109. The response to thromboxane A2 analogues in human platelets. Discrimination of two binding sites linked to distinct effector systems. K Takahara R Murray GA FitzGerald DJ Fitzgerald, J Biol Chem 1990 265 6836 6844
110. Heterogeneity of prostaglandin H2/thromboxane A2 receptors: distinct subtypes mediate vascular smooth muscle contraction and platelet aggregation. L Furci DJ Fitzgerald GA Fitzgerald, J Pharmacol Exp Ther 1991 258 74 81
111. Involvement of endoperoxides and thromboxanes in anaphylactic reactions. M Hamberg J Svensson P Hedqvist K Strandberg B Samuelsson, Adv Prostaglandin Thromboxane Res 1976 1 495 501
112. Metabolism of 8-iso-prostaglandin F2alpha. S Basu, FEBS Lett 1998 428 32 36
113. 11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation. F Catella D Healy JA Lawson GA FitzGerald, Proc Natl Acad Sci USA 1986 83 5861 5865
114. Specific analysis in plasma and urine of 2,3-dinor-5, 6-dihydro-isoprostane F(2alpha)-III, a metabolite of isoprostane F(2alpha)-III and an oxidation product of gamma-linolenic acid. A Burke JA Lawson EA Meagher J Rokach GA FitzGerald, J Biol Chem 2000 275 2499 2504
115. Release of isoprostanes by human pulmonary artery in organ. KB Jourdan JA Mitchell TW Evans, Biochem Biophys Res Commun 1997 233 668 72